NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies

被引：7
作者：
Chen, Pengfei [1 ]
Li, Xia [1 ,2 ]
机构：
[1] Shandong Univ, Marine Coll, Weihai, Peoples R China
[2] Shandong Kelun Pharmaceut Co Ltd, Binzhou, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
基金：
中国国家自然科学基金;
关键词：
NLRP3; inflammasome; atherosclerosis; mechanisms; targeted therapies; small molecule inhibitors; FOAM CELL-FORMATION; SMOOTH-MUSCLE-CELLS; ACTIVATION; APOPTOSIS; DISEASE; PATHOGENESIS; ASC; AUTOINHIBITION; INTERLEUKIN-1; INHIBITION;
D O I：
10.3389/fphar.2024.1430236
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Atherosclerosis (AS) is the primary pathology behind various cardiovascular diseases and the leading cause of death and disability globally. Recent evidence suggests that AS is a chronic vascular inflammatory disease caused by multiple factors. In this context, the NLRP3 inflammasome, acting as a signal transducer of the immune system, plays a critical role in the onset and progression of AS. The NLRP3 inflammasome is involved in endothelial injury, foam cell formation, and pyroptosis in AS. Therefore, targeting the NLRP3 inflammasome offers a new treatment strategy for AS. This review highlights the latest insights into AS pathogenesis and the pharmacological therapies targeting the NLRP3 inflammasome, focusing on optimal targets for small molecule inhibitors. These insights are valuable for rational drug design and the pharmacological assessment of new targeted NLRP3 inflammasome inhibitors in treating AS.
引用
收藏
页数：18
相关论文
共 50 条
[31]   Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis [J].
Singh, Puneetpal ;
Kumar, Nitin ;
Singh, Monica ;
Kaur, Manminder ;
Singh, Gurjinderpal ;
Narang, Amit ;
Kanwal, Abhinav ;
Sharma, Kirti ;
Singh, Baani ;
Napoli, Mario Di ;
Mastana, Sarabjit .
VACCINES, 2023, 11 (02)
[32]   Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis [J].
Yamaguchi, Yohei ;
Kurita-Ochiai, Tomoko ;
Kobayashi, Ryoki ;
Suzuki, Toshihiko ;
Ando, Tomohiro .
PATHOGENS AND DISEASE, 2015, 73 (04)
[33]   The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation [J].
Martinez, Gonzalo J. ;
Celermajer, David S. ;
Patel, Sanjay .
ATHEROSCLEROSIS, 2018, 269 :262-271
[34]   Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction [J].
Silvis, Max J. M. ;
Demkes, Evelyne J. ;
Fiolet, Aernoud T. L. ;
Dekker, Mirthe ;
Bosch, Lena ;
van Hout, Gerardus P. J. ;
Timmers, Leo ;
de Kleijn, Dominique P. V. .
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2021, 14 (01) :23-34
[35]   A Spotlight on the Underlying Activation Mechanisms of the NLRP3 Inflammasome and its Role in Atherosclerosis: A Review [J].
Anam Liaqat ;
Muhammad Asad ;
Fatima Shoukat ;
Arif-Ullah Khan .
Inflammation, 2020, 43 :2011-2020
[36]   Regulation of the NLRP3 inflammasome [J].
Groslambert, Marine ;
Py, Benedicte F. .
M S-MEDECINE SCIENCES, 2018, 34 (01) :47-53
[37]   The Role of NLRP3 Inflammasome in IgA Nephropathy [J].
Wu, Xiaofang ;
Zhao, Lei ;
Li, Kailong ;
Yang, Jurong .
MEDICINA-LITHUANIA, 2023, 59 (01)
[38]   A role for mitochondria in NLRP3 inflammasome activation [J].
Zhou, Rongbin ;
Yazdi, Amir S. ;
Menu, Philippe ;
Tschopp, Juerg .
NATURE, 2011, 469 (7329) :221-225
[39]   Flavonoids interfere with NLRP3 inflammasome activation [J].
Lim, Hyun ;
Min, Dong Suk ;
Park, Haeil ;
Kim, Hyun Pyo .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 355 :93-102
[40]   Role of the NLRP3 inflammasome in the immunopathogenesis of flaviviruses [J].
Cuapa-Gonzalez, Mario A. ;
Marquez-Dominguez, Luis ;
Cortes-Hernandez, Paulina ;
Rojas-Lopez, Marlon ;
Santos-Lopez, Gerardo .
CRITICAL REVIEWS IN MICROBIOLOGY, 2024,
12345